Current Drug Discovery Technologies

Editor-in-Chief:
Vladimir P. Torchilin
Department of Pharmaceutical Science Center
for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA

 

Back

Become EABM
Become Reviewer

Activity Based Chemical Proteomics: Profiling Proteases as Drug Targets

Volume:5   Issue: 3
Pp: 200-212
William Percy Heal, Sasala Roshinie Wickramasinghe and Edward William Tate
DOI: 10.2174/157016308785739866

Current Topics of Organic and Biological Chemistry of Annonaceous Acetogenins and their Synthetic Mimics

Volume:5   Issue: 3
Pp: 213-229
Hidefumi Makabe, Hiroyuki Konno and Hideto Miyoshi
DOI: 10.2174/157016308785739820

SNP Technologies for Drug Discovery: A Current Review

Volume:5   Issue: 3
Pp: 230-235
Joanne Voisey and Charles Phillip Morris
DOI: 10.2174/157016308785739811

Advances in Drug Discovery to Assess Cholinergic Neurotransmission: A Systematic Review

Volume:5   Issue: 3
Pp: 236-249
Vitor F. Ferreira, David R. da Rocha, Katia G. Lima Araujo and Wilson C. Santos
DOI: 10.2174/157016308785739848

RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology

Volume:5   Issue: 3
Pp: 263-268
Kosei Ando, Kanji Mori, Francoise Redini and Dominique Heymann
DOI: 10.2174/157016308785739857